{"id":"W2023398941","doi":"10.1016/j.ygyno.2007.08.084","title":"Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"","keywords":"Carboplatin; Medicine; Ifosfamide; Paclitaxel; Urology; Chemotherapy; Endometrial cancer; Uterine cancer; Oncology; Internal medicine; Cancer; Gynecology; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004851944,0.0003518423,0.0002914434,0.0003666373,0.001004353,0.0006191866,0.0005631192,0.0003798746,0.003143011],"category_scores_gemma":[0.001008377,0.0001795841,0.0002193891,0.0009423165,0.00041472,0.0002510575,0.0004688927,0.001073572,0.0003604881],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005021417,"about_ca_system_score_gemma":0.005334176,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.3941575,"about_ca_topic_score_gemma":0.7533211,"domain_scores_codex":[0.9997547,0.00006708124,0.00001453971,0.00003361307,0.00007941761,0.00005071479],"domain_scores_gemma":[0.9996411,0.00006750144,0.00003290821,0.00001623824,0.00007249579,0.0001698369],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01096633,0.0052579,0.07726863,0.0006670237,0.0003862802,0.006384135,0.002123307,0.002475946,0.01446179,0.001082902,0.02361786,0.8553079],"study_design_scores_gemma":[0.005855247,0.01622068,0.5936954,0.0006337063,0.001367981,0.02327695,0.002585688,0.002816462,0.0100136,0.0007566857,0.3426537,0.0001239927],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9090312,0.03048989,0.0006219433,0.004424277,0.0002121331,0.0003774389,0.0008749402,0.00005307704,0.05391516],"genre_scores_gemma":[0.9470578,0.02989676,0.001139129,0.00156335,0.0001621286,0.00007621595,0.0008050397,0.00005080632,0.0192488],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6058425,"threshold_uncertainty_score":0.7837265,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04979267677869392,"score_gpt":0.3714260174683374,"score_spread":0.3216333406896435,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}